Nexeon MedSystems Inc.

Nexeon MedSystems Inc. is a medical device company that develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders. The company’s neurostimulation technology platform is designed to provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. Nexeon MedSystems Inc. has developed the Viant, a deep brain stimulation system for Parkinson’s disease in the United States and Europe.

Since its founding in 2015, Nexeon MedSystems Inc. has become a leader in the medical device industry, with its innovative neurostimulation technology platform. The company has received numerous awards and recognition for its innovative products, including the 2020 MedTech Breakthrough Award for Best Neurostimulation Technology Platform. Additionally, the company has been featured in numerous publications, including Forbes, The Wall Street Journal, and The New York Times.

Nexeon MedSystems Inc. is headquartered in Dallas, Texas, and has offices in the United States, Canada, Europe, and Asia. The company has a staff of over 200 highly trained professionals, including engineers, scientists, and medical device experts. The company also has an extensive research and development program, which is focused on developing new and innovative technologies to improve the lives of patients with neurological disorders.